Franklin Genomic Advancements Etf Technical Analysis
| HELX Etf | USD 30.28 0.12 0.40% |
As of the 16th of February 2025, Franklin Genomic shows the Coefficient Of Variation of (2,701), mean deviation of 1.06, and Standard Deviation of 1.39. Franklin Genomic Adv technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the entity's future prices.
Franklin Genomic Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Franklin, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to FranklinFranklin |
Franklin Genomic technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Franklin Genomic Adv Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Franklin Genomic Adv volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Franklin Genomic Adv Trend Analysis
Use this graph to draw trend lines for Franklin Genomic Advancements. You can use it to identify possible trend reversals for Franklin Genomic as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Franklin Genomic price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Franklin Genomic Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Franklin Genomic Advancements applied against its price change over selected period. The best fit line has a slop of 0 , which means Franklin Genomic Advancements will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.68, which is the sum of squared deviations for the predicted Franklin Genomic price change compared to its average price change.About Franklin Genomic Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Franklin Genomic Advancements on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Franklin Genomic Advancements based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on Franklin Genomic Adv price pattern first instead of the macroeconomic environment surrounding Franklin Genomic Adv. By analyzing Franklin Genomic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Franklin Genomic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Franklin Genomic specific price patterns or momentum indicators. Please read more on our technical analysis page.
Franklin Genomic February 16, 2025 Technical Indicators
Most technical analysis of Franklin help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Franklin from various momentum indicators to cycle indicators. When you analyze Franklin charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.06 | |||
| Coefficient Of Variation | (2,701) | |||
| Standard Deviation | 1.39 | |||
| Variance | 1.94 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.06) | |||
| Treynor Ratio | (0.1) | |||
| Maximum Drawdown | 6.1 | |||
| Value At Risk | (2.09) | |||
| Potential Upside | 1.8 | |||
| Skewness | (0.90) | |||
| Kurtosis | 1.82 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Franklin Genomic Advancements. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.